Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avadel, Biomind, Clearmind, Cynata, Hyundai, Innocare, Janssen, Merck, Pfizer, Reata, Revive, Roche, Scisparc, Servier.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Academab, Menarini, Mereo, Neurona, Neurosene, Total Brain, Verisim, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrivo, Axcella, Cytomx, Laekna, Modus, Moleculin, Nurix, Q32, Scioto, Sellas, Tikomed, Yingli.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ellipses, Enlivex, Evgen, Insilico, Merck, Novocure, Novomedix, Oxford.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Codagenix, Crinetics, Endeavor, Harbour, Junshi, Karyopharm, Obseva, Osivax, Pharmazz.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antios, Assembly, Astrazeneca, Bavarian Nordic, Citius, Teva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerie, Alnylam, Alvotech, Caladrius, Cingulate, Cytokinetics, Edesa, Eli Lilly, Ensysce, Luxa, Pfizer, Recardio, Springworks, Windtree.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altamira, Astrazeneca, Bharat, Biohaven, Depymed, Eiger, Greenwich, Immunitybio, Immunogen, Nymox, Ocugen, Regeneron, Salubris, Sanofi, Therapeuticsmd.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antares, Benevira, Biomx, Blade, CASI, Clearmind, Dongcheng, Galapagos, Genocea, Halozyme, Insilico, Imaginab, Journey, Kalivir, Knight, Padagis, Rigel, Roche, RS, Scipher, Scisparc, Synthonics, Sparrow, Tianshi, ZZ.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alnylam, Antengene, Armata, Aurinia, Biond, Chinook, Compass, Concert, Day One, Hansa, Idorsia, Janssen, Liminal, Neurocrine, Pfizer, Polypid, Rapt, Regeneron, Salubris, Saniona, Seagen, Stealth, Tenax, Teva, UCB, Visen.